Treatment of Advanced Intrahepatic Cholangiocarcinoma

NCT03940378 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

ICC

Interventions

DRUG: Levamisole Hydrochloride
DRUG: Anlotinib Hydrochloride Capsules

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]